Antaros Medical presents First-in-class PET tracer for the glucagon receptor at EASD 2017

September 12th, 2017

Antaros Medical, in collaboration with Sanofi, presents important data at the 53rd Annual Meeting of the European Association for the study of diabetes (EASD) on a first-in-class Glucagon (GCG) Positron Emission Tomography (PET) ligand, with suitable properties for clinical development targeting the glucagon receptor.




In addition, Antaros founders contribute to science at EASD 2017 in three additional poster:


Pereira MJ, Skrtic A, Katsogiannos P,  Abrahamsson N, Kullberg J, Nowak C, Eriksson JW


Boersma GJ, Heurling K, Pereira MJ, Johansson E, Lubberink M, B
örjesson JL, Katsogiannos P, Skrtic S, Kullberg J, Ahlström H, Eriksson JW



Hyypia A, Makine J, Oscarsson J, Hannukainen J, Kullberg J, Johansson L, Nuutila P, Miikka-Juhani Honka MJ


Back to all news